WEX Inc. (WEX) AI Stock Analysis
WEX AI stock analysis summary
AI ResearchWEX Inc. provides global financial technology services across fleet payments, corporate disbursements, and healthcare benefits. For the trailing twelve months, the company generated $2.79B in revenue with an operating margin of 26.9% and diluted EPS of $10.03. In the latest quarter ended June 30, 2026, quarterly revenue grew 14.2% year-over-year while quarterly earnings expanded 57.1%.
- Market cap
- $6.20B
- Revenue (TTM)
- $2.79B
- P/E
- 18.1x fwd 8.6x
- 1Y return
- 23.3% S&P 500 16.8%
- Avg. target
- $195.36 7.3% vs last close
Bull case
- WEX achieved 14.2% quarterly revenue growth and 57.1% quarterly earnings growth year-over-year in the quarter ended June 30, 2026.
- Valuation multiples remain discounted to peers, with a forward P/E of 8.6x and EV-to-EBITDA of 5.2x versus US-listed Technology medians of 18.8x and 16.6x.
- Share repurchases were aggressive in FY2025 at $799.8M, helping reduce the total share count by 22.2% over 5 years.
Bear case
- Top-line annual growth slowed significantly in recent years, decelerating from 27.0% in FY2022 to 1.2% in FY2025.
- Longer-term equity returns have lagged the broad market, posting a 5-year return of -5.7% against the S&P 500 return of 83.0%.
- The company holds $5.36B in total debt against $1.34B in shareholders' equity, reflecting a high debt-to-equity ratio of 3.98.
What WEX does
WEX Inc. specializes in delivering financial technology services globally across three primary segments: Fleet Solutions, Travel and Corporate Solutions, and Health and Employee Benefit Solutions. Fleet Solutions provides payment processing, billing, credit management, and analytics to commercial and government fleets via direct sales and partner arrangements. Travel and Corporate Solutions delivers embedded payment solutions, virtual cards, and accounts payable automation tools for commercial and government entities. Health and Employee Benefit Solutions provides healthcare payment products and software-as-a-service platforms for consumer-directed healthcare management, as well as payroll-related and employee benefit products tailored for the Brazilian market.
Growth and profitability
WEX delivered a 5-year revenue CAGR of 11.3% from FY2020 to FY2025. Annual revenue grew from $1.85B in FY2021 to $2.35B in FY2022, $2.55B in FY2023, $2.63B in FY2024, and reached $2.66B in FY2025. Net income stood at $100,000 in FY2021, rose to $201.4M in FY2022, settled at $14.8M in FY2023, before climbing to $309.6M in FY2024 and $304.1M in FY2025. Operating margin was 25.4% in FY2025 compared to 26.1% in FY2024 and 0.6% in FY2023. Over the trailing twelve months, revenue totaled $2.79B with a profit margin of 12.6%. In the latest quarter ended June 30, 2026, revenue increased 14.2% and earnings increased 57.1% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, WEX held $6.10B in cash and short-term investments against $5.36B in total debt, resulting in net cash of $744.4M. Shareholders' equity was $1.34B out of $16.50B in total assets, with a current ratio of 1.04 and a debt-to-equity ratio of 3.98. Operating cash flow in FY2025 was $454.3M, yielding free cash flow of $313.7M after capital expenditures of $140.6M. Capital allocation in FY2025 included $799.8M directed to share buybacks, contributing to a 5-year share count reduction of 22.2%.
Valuation and performance
At a share price of $182.01, WEX carries a market cap of $6.20B and an enterprise value of $5.43B. The stock trades at a trailing P/E of 18.1x and a forward P/E of 8.6x, compared to medians of 28.1x and 18.8x, respectively, for its US-listed Technology peers. Its EV-to-EBITDA stands at 5.2x, below the peer group median of 16.6x, while its price-to-sales multiple is 2.2x versus the peer median of 2.8x. Over the past year, WEX gained 23.3%, outperforming the S&P 500 return of 16.8%, but its 5-year return of -5.7% trails the index return of 83.0%.
What analysts expect
Wall Street coverage on WEX includes 4 Strong Buy, 1 Buy, and 10 Hold ratings, with no Sell or Strong Sell ratings. The consensus mean price target is $195.36, representing 7.3% upside from the last close of $182.01. Analysts project current fiscal year EPS of $20.14 on revenue of $2.90B, followed by next fiscal year EPS of $21.29 on revenue of $2.94B based on 15 analysts. The company beat EPS estimates in each of the last 4 quarters, with its next earnings date scheduled for October 28, 2026.
Key risks and what to watch
- Short interest is elevated, with short percent of float standing at 10.7%.
- Next fiscal year revenue growth is estimated by analysts to slow to 1.6%, reaching $2.94B.
- Balance sheet leverage remains elevated with a debt-to-equity ratio of 3.98 and a current ratio of 1.04.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this WEX AI stock analysis
This page is an AI-written research summary of WEX Inc. (WEX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: WEX income statement, WEX balance sheet, WEX key metrics, WEX analyst forecast, WEX chart. See the WEX stock overview for the latest quote and news.
WEX AI stock analysis FAQ
What is WEX's valuation relative to its industry peers?
WEX trades at a forward P/E of 8.6x and an EV-to-EBITDA of 5.2x, both below the US-listed Technology peer medians of 18.8x and 16.6x, respectively.
Does WEX pay a dividend?
WEX does not currently pay a dividend, prioritizing capital return through share repurchases, which totaled $799.8M in FY2025.
What are analysts' price targets and expectations for WEX?
Analysts have a mean price target of $195.36, representing a 7.3% upside to the last closing price of $182.01, with current fiscal year EPS projected at $20.14.
When is WEX reporting earnings next?
The company is scheduled to report its next earnings release on October 28, 2026, following 4 consecutive quarters of beating EPS estimates.